Zobrazeno 1 - 1
of 1
pro vyhledávání: '"G Kats-Urgulu"'
Autor:
A Van Der Waaij, R Gabriëls, M Linssen, P Volkmer, D Robinson, M Hermoso, A Karrenbeld, E Festen, G Dijkstra, G Kats-Urgulu, W Nagengast
Publikováno v:
Journal of Crohn's and Colitis. 17:i944-i945
Background Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism